Abstract
This patent describes the series of compounds and their pharmaceutically acceptable salts, such as compound K7 (as a representative potent compound). These protein kinase C selective inhibitors are useful for treating diabetes mellitus and its complications, cancer, ischemia, inflammation, central nervous system disorders, cardiovascular disease, Alzheimer's disease, dermatological disease pression, virus diseases, inflammatory disorders, or diseases in which the liver is a target organ.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have